• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质结晶模型的集成/不确定性量化方法

Integrated / Uncertainty Quantification Method for Protein Crystallization Models.

作者信息

Pessina Daniele, Calderon De Anda Jorge, Heffernan Claire, Heng Jerry Y Y, Papathanasiou Maria M

机构信息

Department of Chemical Engineering, Imperial College London, London SW7 2AZ, United Kingdom.

The Sargent Centre for Process Systems Engineering, Imperial College London, London SW7 2AZ, United Kingdom.

出版信息

Ind Eng Chem Res. 2025 Jun 5;64(24):12025-12035. doi: 10.1021/acs.iecr.4c04517. eCollection 2025 Jun 18.

DOI:10.1021/acs.iecr.4c04517
PMID:40568535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12186480/
Abstract

The complexity of protein crystallization and modeling challenges process intensification and the wider adoption of crystallization in biomanufacturing. For computational models to support and replace extensive experiments, they must accurately reflect experiments. However, parameter estimation can be ineffective due to the highly nonlinear model structure and inaccurate online process analytical technology, which must be addressed. In this work, an experimentally validated and model-driven parametrization methodology is presented, developed for an antisolvent batch protein crystallization system with limited offline measurements. Global sensitivity analysis is performed to assess parameter identifiability during batch operations and inform optimal measurement points. Experiments at three different initial lysozyme concentrations ( = 15, 18, 19 mg/mL) are used for estimation. Parameter uncertainty distributions are recovered through an Approximate Bayesian Computation algorithm and propagated to model outputs through Monte Carlo simulations, avoiding linearization or unnecessary assumptions on the parametric and output uncertainty distributions. The methodology was successfully validated under two new experimental conditions. The shapes of the recovered parametric and output uncertainties highlight the need for parameter estimation methodologies specifically tailored to nonlinear models.

摘要

蛋白质结晶和建模的复杂性给生物制造过程强化以及更广泛地采用结晶技术带来了挑战。对于计算模型而言,要支持并取代大量实验,就必须准确反映实验情况。然而,由于模型结构高度非线性以及在线过程分析技术不准确,参数估计可能效率低下,这些问题必须加以解决。在这项工作中,我们提出了一种经过实验验证且由模型驱动的参数化方法,该方法是针对离线测量有限的反溶剂间歇式蛋白质结晶系统开发的。进行全局敏感性分析以评估间歇操作期间的参数可识别性,并确定最佳测量点。使用三种不同初始溶菌酶浓度(= 15、18、19 mg/mL)下的实验进行估计。通过近似贝叶斯计算算法恢复参数不确定性分布,并通过蒙特卡罗模拟将其传播到模型输出,避免对参数和输出不确定性分布进行线性化或不必要的假设。该方法在两个新的实验条件下成功得到验证。恢复的参数和输出不确定性的形状凸显了针对非线性模型专门定制参数估计方法的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/1afeaa9470fd/ie4c04517_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/80fddb57a056/ie4c04517_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/6dac532d8f80/ie4c04517_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/cc64d2cf5d8a/ie4c04517_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/5109e8afb63f/ie4c04517_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/f82d6bbbb99c/ie4c04517_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/1afeaa9470fd/ie4c04517_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/80fddb57a056/ie4c04517_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/6dac532d8f80/ie4c04517_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/cc64d2cf5d8a/ie4c04517_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/5109e8afb63f/ie4c04517_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/f82d6bbbb99c/ie4c04517_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4414/12186480/1afeaa9470fd/ie4c04517_0006.jpg

相似文献

1
Integrated / Uncertainty Quantification Method for Protein Crystallization Models.蛋白质结晶模型的集成/不确定性量化方法
Ind Eng Chem Res. 2025 Jun 5;64(24):12025-12035. doi: 10.1021/acs.iecr.4c04517. eCollection 2025 Jun 18.
2
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
3
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
6
Intracavity lavage and wound irrigation for prevention of surgical site infection.腔内灌洗和伤口冲洗预防手术部位感染
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD012234. doi: 10.1002/14651858.CD012234.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Reaction kinetics determination and uncertainty analysis for the synthesis of the cancer drug lomustine.癌症药物洛莫司汀合成的反应动力学测定及不确定度分析
Chem Eng Sci. 2023;275. doi: 10.1016/j.ces.2023.118591. Epub 2023 Jul 6.
2
Protein Nucleation and Crystallization Process with Process Analytical Technologies in a Batch Crystallizer.间歇结晶器中基于过程分析技术的蛋白质成核与结晶过程
Cryst Growth Des. 2023 Jun 20;23(7):5181-5193. doi: 10.1021/acs.cgd.3c00411. eCollection 2023 Jul 5.
3
Studying the impact of the pre-exponential factor on templated nucleation.
研究前置因子对模板成核的影响。
Faraday Discuss. 2022 Jul 14;235(0):199-218. doi: 10.1039/d1fd00101a.
4
Anything but Conventional Chromatography Approaches in Bioseparation.生物分离中非常规的色谱方法。
Biotechnol J. 2020 Aug;15(8):e1900274. doi: 10.1002/biot.201900274. Epub 2020 May 11.
5
Statistical Analysis and Nucleation Parameter Estimation from Nucleation Experiments in Flowing Microdroplets.流动微滴成核实验的统计分析与成核参数估计
Cryst Growth Des. 2019 Nov 6;19(11):6159-6174. doi: 10.1021/acs.cgd.9b00562. Epub 2019 Sep 19.
6
Affinity Chromatography: An Enabling Technology for Large-Scale Bioprocessing.亲和层析:大规模生物加工的一项使能技术。
Biotechnol J. 2020 Jan;15(1):e1800397. doi: 10.1002/biot.201800397. Epub 2019 Oct 25.
7
Emerging biomaterials for downstream manufacturing of therapeutic proteins.用于治疗性蛋白下游制造的新兴生物材料。
Acta Biomater. 2019 Sep 1;95:73-90. doi: 10.1016/j.actbio.2019.03.015. Epub 2019 Mar 9.
8
Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients.肽类疗法与制药行业:从实验室到患者的转化过程中遇到的障碍。
Curr Med Chem. 2016;23(37):4231-4259. doi: 10.2174/0929867323666160909155222.
9
Do protein crystals nucleate within dense liquid clusters?蛋白质晶体是否在致密液体团簇中形成晶核?
Acta Crystallogr F Struct Biol Commun. 2015 Jul;71(Pt 7):815-22. doi: 10.1107/S2053230X15008997. Epub 2015 Jun 27.
10
Large-scale crystallization of proteins for purification and formulation.用于纯化和制剂的蛋白质大规模结晶。
Bioprocess Biosyst Eng. 2015 Jul;38(7):1209-31. doi: 10.1007/s00449-015-1374-y. Epub 2015 Feb 21.